RemSleep Holdings (RMSL) Cash & Equivalents (2011 - 2025)
RemSleep Holdings recorded quarterly Cash & Equivalents of $214514.0 in Q4 2025, down 37.63% quarter-over-quarter from $343948.0 in Q3 2025, and down 53.7% year-over-year from $463343.0 in Q4 2024.
RemSleep Holdings' Cash & Equivalents history runs 14 years deep, the most recent figure standing at $214514.0 for Q4 2025.
- In Q4 2025, Cash & Equivalents fell 53.7% year-over-year to $214514.0; the TTM figure through Dec 2025 stood at $214514.0 (down 53.7% YoY), while the FY2025 annual figure was $214514.0, down 53.7% from the prior year.
- Cash & Equivalents came in at $214514.0 for Q4 2025 at RemSleep Holdings, down from $343948.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $4.0 million in Q1 2022 to a low of $158873.0 in Q1 2021.
- A 5-year average of $1.2 million and a median of $724862.5 in 2023 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents jumped 2862.14% in 2021 and tumbled 63.51% in 2023, its largest moves.
- RemSleep Holdings' Cash & Equivalents stood at $3.4 million in 2021, then plunged by 45.56% to $1.8 million in 2022, then tumbled by 60.96% to $719100.0 in 2023, then plunged by 35.57% to $463343.0 in 2024, then tumbled by 53.7% to $214514.0 in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $214514.0, $343948.0, and $415975.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 | 214,514.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 214,514.00 |
| Sep 30, 2025 | 343,948.00 |
| Jun 30, 2025 | 415,975.00 |
| Mar 31, 2025 | 507,247.00 |
| Dec 31, 2024 | 463,343.00 |
| Sep 30, 2024 | 534,714.00 |
| Jun 30, 2024 | 698,727.00 |
| Mar 31, 2024 | 730,625.00 |
| Dec 31, 2023 | 719,100.00 |
| Sep 30, 2023 | 904,363.00 |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.84 Mn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 3.38 Mn |
| Sep 30, 2021 | 2.36 Mn |
| Jun 30, 2021 | 350,893.00 |
| Mar 31, 2021 | 158,873.00 |
| Dec 31, 2020 | 114,227.00 |
| Sep 30, 2020 | 96,838.00 |
| Jun 30, 2020 | 47,740.00 |
| Mar 31, 2020 | 253,667.00 |
| Dec 31, 2019 | 119,574.00 |
| Sep 30, 2019 | 101,687.00 |
| Jun 30, 2019 | 181,763.00 |
| Mar 31, 2019 | 44,352.00 |
| Dec 31, 2018 | 16,640.00 |
| Sep 30, 2018 | 40,955.00 |
| Jun 30, 2018 | 553.00 |
| Mar 31, 2018 | 52,261.00 |
| Dec 31, 2017 | 2,014.00 |
| Sep 30, 2017 | 55.00 |
| Dec 31, 2015 | 108.00 |
| Mar 31, 2014 | 158.00 |
| Sep 30, 2013 | -1.00 |
| Jun 30, 2013 | 158.00 |
| Mar 31, 2013 | 700.00 |
| Dec 31, 2012 | 478.00 |
| Sep 30, 2012 | 18,760.00 |
| Jun 30, 2012 | 3,776.00 |
| Mar 31, 2012 | 3,776.00 |
| Dec 31, 2011 | 6,309.00 |
| Sep 30, 2011 | 45,881.00 |